Pharmaceutical Statistics
© John Wiley & Sons, Ltd.

Editors-in-Chief: Oliver Keene, Lisa LaVange and Kit Roes
Impact Factor: 2.067
ISI Journal Citation Reports © Ranking: 2011: 10/116 (Statistics & Probability); 139/261 (Pharmacology & Pharmacy)
Online ISSN: 1539-1612
Recently Published Issues
Current Issue:March/April 2013
Volume 12, Issue 2
Volume 12, Issue 1
Volume 11, Issue 6
Volume 11, Issue 5
Volume 11, Issue 4
Stay Ahead with Pharmaceutical Statistics
![]() |
![]() |
Read these top cited papers:
Guidelines for accurate EC50/IC50 estimation
![]() |
Read these most accessed papers:
A guide to the design and analysis of small clinical studies
![]() |
Pharmaceutical Statistics OnlineOpen
OnlineOpen – The Open Access Option for Authors
OnlineOpen is available to authors who wish to make their article open access, free to read, download and share via Wiley Online Library and PubMed Central. Read this recent OnlineOpen article. Yours can be too. Learn more about OnlineOpen.
Escalation strategies for combination therapy Phase I trials
Michael J. Sweeting and Adrian P. Mander
![]() |
Pharmaceutical Statistics Journal Club
The latest Joint PSI's Pharmaceutical Statistics and RSS Journal Club Meeting on Survival Analysis took place on 16th April.
The key papers discussed were:
Find out more at http:/www.psiweb.org/journalclub
PSI Conference 2013
This year, the closing session at 11:30 on Wed 15th May celebrates 10 years of Pharmaceutical Statistics.
Pharmaceutical Statistics, PSI’s own journal, has been around for more than 10 years, and during this time, has seen the publication of many important and influential papers. In this session, PSI have picked one such paper (“Assurance in Clinical Trial Design”, by A. O’Hagan, J.W. Stevens and M.J. Campbell, Pharmaceutical Statistics 4, 187-201, 2005) to be presented by one of the authors, in the style of an RSS Ordinary meeting.
Find out more at http://www.psiweb.org
Pharmaceutical Statistics
New Editor-in-Chief
We are delighted to welcome Oliver Keene as one of three Editors-in-Chief of Pharmaceutical Statistics. Oliver studied mathematics at Cambridge University before completing an MSc in statistics at University College, London.
![]() |
Don't Miss the Latest Pharmaceutical Statistics Special Issue

1539-1612/asset/olbannerleft.jpg?v=1&s=b3f2157bd7aaef490b616207a089ae32159b3a46)
1539-1612/asset/olbannerright.jpg?v=1&s=1c0d39d668c2e781107975b035cd3bee9047931d)
1539-1612/asset/homepages/09-Alerts.jpg?v=1&s=e97dc24cd50fdba9bf6e6a9a37e03171e071b6fc)
1539-1612/asset/homepages/47217-stats-LL-generic-early-view-button-WEBREADY.gif?v=1&s=fb881c5b9d2448a67dc1adc58a22d6e4539a3b96)
1539-1612/asset/homepages/19-Most-Cited-Articles.jpg?v=1&s=a4975060e5163a0ad77013647d2b204824905cad)
1539-1612/asset/homepages/18-Most-Read-Articles.jpg?v=1&s=5b137d61b0936622c23ac8eac611ba23d907f533)
1539-1612/asset/homepages/OnlineOpen_160x160_MASTER.gif?v=1&s=0944f1dd1c14af3db2b8ebe7fe384891aeb349b6)
1539-1612/asset/homepages/PST.jpg?v=1&s=56cf6d1f08aea48e8f61d2c45ae8cbe5dc395beb)
1539-1612/asset/homepages/PST_EIC.jpg?v=1&s=9dfae502999d610e4937958705b98387e8303dff)
1539-1612/asset/homepages/14-Special-Issues.jpg?v=1&s=ea75c3973cb339da770d3cfabe6886badea7940b)
1539-1612/asset/society1image.jpg?v=1&s=46a03f8baee77af6d16ad7ca1b40666780700b06)